Quantamental Technologies’s Oruka Therapeutics ORKA Stock Holding History

Quantamental Technologies’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-201	Closed	-$13K	–	1383
2019 Q3	$13K	Sell	201 -228	-53%	-$16.8K	﹤0.01%	1282
2019 Q2	$38K	Buy	+429	New	+$38.5K	0.01%	989

Other funds holding ORKA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantamental Technologies's ORKA Position: Q4 2019 in Review

Quantamental Technologies sold out of Oruka Therapeutics (ORKA) in Q4 2019, closing a stake of 201 shares — an estimated $13K sold.

Quantamental Technologies first reported a position in ORKA in Q2 2019 and held it in 2 quarters. The position peaked at $38K in Q2 2019. 12 funds tracked by Wall St. Rank hold ORKA as of Q4 2019.

Quantamental Technologies reported no remaining Oruka Therapeutics position as of Q4 2019 after selling out during the quarter.
Quantamental Technologies sold 201 Oruka Therapeutics shares in Q4 2019, an estimated $13K.
Quantamental Technologies first reported a position in Oruka Therapeutics in Q2 2019 and held it in 2 quarters.
Quantamental Technologies's Oruka Therapeutics position peaked at $38K in Q2 2019.
12 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.